Yifan Pharmaceutical(002019.SZ)Famotidine injection has obtained drug registration certificate.

date
18/09/2024
avatar
GMT Eight
Yifan Pharmaceutical (002019.SZ) announced that its wholly-owned subsidiary, Hefei Yifan Biopharmaceutical Co., Ltd., recently received the "Drug Registration Certificate" issued by the National Medical Products Administration for Famotidine Injection. Famotidine Injection is mainly used for upper gastrointestinal bleeding caused by digestive ulcers and mucosal erosion and bleeding in the stomach and duodenum caused by various reasons other than tumors and esophageal or gastric varices.

Contact: contact@gmteight.com